These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 14007905)

  • 1. Comparison of psilocin with psilocybin, mescaline and LSD-25.
    WOLBACH AB; MINER EJ; ISBELL H
    Psychopharmacologia; 1962; 3():219-23. PubMed ID: 14007905
    [No Abstract]   [Full Text] [Related]  

  • 2. Mescaline, lysergic acid diethylamide and psilocybin comparison of clinical syndromes, effects on color perception and biochemical measures.
    HOLLISTER LE; HARTMAN AM
    Compr Psychiatry; 1962 Aug; 3():235-42. PubMed ID: 13908449
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.
    Ley L; Holze F; Arikci D; Becker AM; Straumann I; Klaiber A; Coviello F; Dierbach S; Thomann J; Duthaler U; Luethi D; Varghese N; Eckert A; Liechti ME
    Neuropsychopharmacology; 2023 Oct; 48(11):1659-1667. PubMed ID: 37231080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the reactions induced by psilocybin and LSD-25 in man.
    ISBELL H
    Psychopharmacologia; 1959; 1():29-38. PubMed ID: 14405870
    [No Abstract]   [Full Text] [Related]  

  • 5. Cross tolerance between mescaline and LSD-25, with a comparison of the mescaline and LSD reactions.
    WOLBACH AB; ISBELL H; MINER EJ
    Psychopharmacologia; 1962 Mar; 3():1-14. PubMed ID: 14007904
    [No Abstract]   [Full Text] [Related]  

  • 6. Cross tolerance between LSD and psilocybin.
    ISBELL H; WOLBACH AB; WIKLER A; MINER EJ
    Psychopharmacologia; 1961; 2():147-59. PubMed ID: 13717955
    [No Abstract]   [Full Text] [Related]  

  • 7. Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'.
    Koerner J; Appel JB
    Psychopharmacology (Berl); 1982; 76(2):130-5. PubMed ID: 6805022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mescaline, LSD, psilocybin, and personality change.
    UNGER SM
    Psychiatry; 1963 May; 26():111-25. PubMed ID: 13995386
    [No Abstract]   [Full Text] [Related]  

  • 9. [Psychopsychic correlations under the effect of psycholytics (LSD, psilocybin and similar drugs)].
    HOLFELD H
    Med Exp Int J Exp Med; 1961; 5():209-14. PubMed ID: 13908338
    [No Abstract]   [Full Text] [Related]  

  • 10. EFFECT OF MESCALINE, LYSERGIC ACID DIETHYLAMIDE AND PSILOCYBIN ON COLOR PERCEPTION.
    HARTMAN AM; HOLLISTER LE
    Psychopharmacologia; 1963 Aug; 4():441-51. PubMed ID: 14048565
    [No Abstract]   [Full Text] [Related]  

  • 11. Addressing the Current Knowledge and Gaps in Research Surrounding Lysergic Acid Diethylamide (LSD), Psilocybin, and Psilocin in Rodent Models.
    Ezeaka UC; Kim HJJ; Laprairie RB
    Curr Top Med Chem; 2023; 23(23):2232-2241. PubMed ID: 37409550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in spider webs brought about by mescaline, psilocybin and an increase in body weight.
    CHRISTIANSEN A; BAUM R; WITT PN
    J Pharmacol Exp Ther; 1962 Apr; 136():31-7. PubMed ID: 13879288
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of LSD-25, psiolocybin, and psilocin on temporal lobe EEG patterns and learned behavior in the cat.
    ADEY WR; BELL FR; DENNIS BJ
    Neurology; 1962 Sep; 12():591-602. PubMed ID: 13859403
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of lysergic acid diethylamide and mescaline-derived hallucinogens on sensory-integrative function: tactile startle.
    Geyer MA; Petersen LR; Rose GJ; Horwitt DD; Light RK; Adams LM; Zook JA; Hawkins RL; Mandell AJ
    J Pharmacol Exp Ther; 1978 Dec; 207(3):837-47. PubMed ID: 731434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. THE HALLUCINOGENIC DRUGS.
    BARRON F; JARVIK ME; BUNNELL S
    Sci Am; 1964 Apr; 210():29-37. PubMed ID: 14143391
    [No Abstract]   [Full Text] [Related]  

  • 16. The action of tryptamine on the dog spinal cord and its relationship to the agonistic actions of LSD-like psychotogens.
    Martin WR; Eades CG
    Psychopharmacologia; 1970; 17(3):242-57. PubMed ID: 5310035
    [No Abstract]   [Full Text] [Related]  

  • 17. CLINICAL SYNDROMES AND BIOCHEMICAL ALTERATIONS FOLLOWING MESCALINE, LYSERGIC ACID DIETHYLAMIDE, PSILOCYBIN AND A COMBINATION OF THE THREE PSYCHOTOMIMETIC DRUGS.
    HOLLISTER LE; SJOBERG BM
    Compr Psychiatry; 1964 Jun; 5():170-8. PubMed ID: 14156873
    [No Abstract]   [Full Text] [Related]  

  • 18. Mescaline: The forgotten psychedelic.
    Vamvakopoulou IA; Narine KAD; Campbell I; Dyck JRB; Nutt DJ
    Neuropharmacology; 2023 Jan; 222():109294. PubMed ID: 36252614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminable stimuli produced by hallucinogens.
    Kuhn DM; White FJ; Appel JB
    Psychopharmacol Commun; 1976; 2(4):345-8. PubMed ID: 996285
    [No Abstract]   [Full Text] [Related]  

  • 20. Psilocybin-induced stimulus control in the rat.
    Winter JC; Rice KC; Amorosi DJ; Rabin RA
    Pharmacol Biochem Behav; 2007 Oct; 87(4):472-80. PubMed ID: 17688928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.